BioCertica's Triumph: Spotlight on South African Health Tech Excellence in the i3 Program with the Gates Foundation Endorsement 🌍✨

September 21, 2023 Gert van Wyk

🌍 BioCertica: Among the Elite Four South African Health Startups Chosen for the i3 Program! 🌍

29 AFRICAN STARTUPS IN HEALTHCARE SUPPLY CHAIN SELECTED TO RECEIVE FUNDING AND IMPACT SUPPORT FROM THE GATES FOUNDATION, MSD

In a significant achievement for South African innovation, BioCertica proudly announces its selection among just four health startups from South Africa in the acclaimed pan-African Investing in Innovation (i3) program. This distinction underscores our pioneering role in the South African health tech landscape.

Key Highlights:

South African Excellence: Being one of only four health startups from South Africa chosen for this cohort emphasizes our unique value proposition and the trust placed in our solutions.
Pan-African Impact: The i3 program, funded by the Bill & Melinda Gates Foundation and supported by major players such as Cencora, MSD, Microsoft, and Chemonics, is a beacon of support for startups reshaping healthcare supply chains across Africa.
Tailored Support: BioCertica, as a recipient, will benefit from a substantial $50,000 grant, opportunities to access markets, and specialized investment readiness support from top-tier accelerators.
Diverse Innovations: BioCertica stands alongside 28 other startups from 21 African countries, all united in the mission to innovate healthcare supply chains with solutions spanning online pharmacies, telemedicine, inventory management, and more.
Milestone Event: The journey gets even more exciting with the upcoming i3’s annual Access to Markets event in Nairobi on 14-15 November. This platform promises strategic partnerships, pilot projects, and enriched engagement with global industry stakeholders.

This recognition is not just an accolade for BioCertica but a testament to the potential and caliber of South African health tech innovations on the global stage. We are profoundly thankful for this opportunity and remain unwavering in our dedication to revolutionizing healthcare.

To get a deeper insight, check out the complete press release.